Directorate Changes

24th May 2021

Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces the appointment of Dr Alastair Riddell as Non-Executive Chairman of the Board with immediate effect. In addition, the Company announces the resignations of Dr Karl Keegan as Non-Executive Director and Dr Joanne Holland as Chief Scientific Officer.

Download News

Back to all News